Clinical Trial

Study Regarding the Incidence of Anti-platelet Factor 4-antibodies in Patients Aged 18 to 60 Years With Spontaneous or Infection- or Vaccine-associated or Recurrent Venous and/or Arterial Thrombosis

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 21, 2024 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
Prospective investigation of the incidence of anti-platelet factor 4 antibodies in suspected immune-associated arterial and/or venous thrombosis
Trial Details
NCT Number NCT06650826
Lead Sponsor Cardioangiologisches Centrum Bethanien
Conditions Arterial or Venous Thrombosis
Enrollment 200 participants
Start Date 2024-07-01
Primary Completion 2026-07 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2024-10-21